Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE007206 |
ID: | TCMBANKHE007206 |
植物拉丁名: |
|
功能与主治: | To promote the flow of qi in the heart, to warm the spleen and stomach, to increse appetite, and to relieve pain./Pain in chest and abdomen, cold stomachache, vomiting of water due to congealing cold qi stagnation, coronary heart disease with pattern of qi stagnation and blood stasis. |
药用植物名: | 檀香 |
药用部位: | heartwood |
药味: | Warm; Pungent |
经络: | Spleen; Stomach; Kidney |
治疗类型: | 理气药 |
TCM_ID_id: | 3390 |
SymMap_id: | 389 |
TCMSP_id: | 683 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN003060 | ()-Valencene | 75056_FLUKA; (3R,4aR,5R)-4a,5-dimethyl-3-prop-1-en-2-yl-2,3,4,5,6,7-hexahydro-1H-naphthalene; W344303_ALDRICH; (3R,4aR,5R)-3-isopropenyl-4a,5-dimethyl-2,3,4,5,6,7-hexahydro-1H-naphthalene; (3R,4aS,5R)-4a,5-Dimethyl-3-isopropenyl-1,2,3,4,4a,5,6,7-octahydronaphthalene | C15H24 | 204.35 | CC1CCC=C2C1(CC(CC2)C(=C)C)C |
| TCMBANKIN003192 | (1S,2S,4R)-2-methyl-3-methylene-2-(4-methylpent-3-enyl)norbornane | (1S,4R,6S)-6-methyl-5-methylidene-6-(4-methylpent-3-enyl)bicyclo[2.2.1]heptane | C15H24 | 204.35 | |
| TCMBANKIN003781 | santenone alcohol | AC1NT07F; 4,7-dimethylbicyclo[2.2.1]heptan-3-ol | CC1C2CCC1(C(C2)O)C | ||
| TCMBANKIN004172 | (2S)-2-amino-3-[(2R)-2-amino-3-hydroxy-3-oxopropyl]disulfanylpropanoic acid | PDSP2_001252; (2S)-2-amino-3-[(2R)-2-amino-3-hydroxy-3-oxo-propyl]disulfanyl-propanoic acid; (2S)-2-amino-3-[(2R)-2-amino-3-hydroxy-3-keto-propyl]disulfanyl-propionic acid; PDSP1_001268 | C6H12N2O4S2 | 240.3 | C(C(C(=O)O)N)SSCC(C(=O)O)N |
| TCMBANKIN005741 | Istidina | EINECS 200-745-3; (S)-2-Amino-3-(4-imidazolyl)propionic acid; HISTIDINE, L-; 35558-59-9; S-Histidine; L-Histidin; Polyhistidine; (L)-Histidine; FEMA No. 3694; 54166-13-1; 53319_FLUKA; (2S)-2-amino-3-(3H-imidazol-4-yl)propanoic acid; AI3-26558; NSC 137773; 1H-Imidazole-4-propanoic acid, alpha-amino-, (S)-; H8000_SIAL; (S)-alpha-Amino-1H-imidazole-4-propionic acid; Histidine (USP/INN); 35479-49-3; L-Histidine, homopolymer; 6459-59-2 (MONOHYDROCHLORIDE); D00032; Histidina [INN-Spanish]; Histidine [USAN:INN]; 30641-68-0; (2S)-2-amino-3-(3H-imidazol-4-yl)propionic acid; H3911_SIAL; Lopac-H-8125; L-beta-(4-Imidazolyl)alanin; CHEBI:15971; C00135; Histidinum [INN-Latin]; H6034_SIGMA; Lopac0_000566; 155304-24-8; 26062-48-6; (2S)-2-amino-3-(1H-imidazol-4-yl)propanoic acid; L-Alanine, 3-(1H-imidazol-4-yl)-; InChI=1/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11; 150-35-6; (S)-4-(2-Amino-2-carboxyethyl)imidazole; Poly(L-histidine); L-Histidine (JAN); AIDS020253; (S)-2-Amino-3-(4-imidazolyl)propionsaeure; AIDS-020253; 4-(2-Amino-2-carboxyethyl)imidazole; Histidine (VAN); 45955-20-2; 1H-Imidazole-4-alanine, (S)-; alpha-Amino-4(or 5)-imidazolepropionic acid; HSDB 1810; HIS NH3+ COOH; alpha-Amino-1H-imidazole-4-propionic acid, (S)-; Polyhiustidine; Imidazole C-4(5) deriv. 5; L-beta-(4-Imidazolyl)-alpha-alanin; NCGC00015518-01; Anti-rheuma | C6H9N3O2 | 155.15 g/mol | C1=C(NC=N1)CC(C(=O)O)N |
| TCMBANKIN006148 | bisabolenol d | C15H26O | 222.37 g/mol | CC1C=CC(C=C1)C(C)CCC(C(C)C)O | |
| TCMBANKIN006438 | SANTALIN | NSC59267; 5,7-dihydroxy-6-methoxy-1,2,3,4-tetrahydroanthracene-9,10-quinone; santalin; 5,7-Dihydroxy-6-methoxy-1,2,3,4-tetrahydroanthracene-9,10-dione; NCI60_004443; 7400-10-4; NSC 59267; AIDS-014747; AIDS014747 | C15H14O5 | 274.27 g/mol | COC1=C(C=C2C(=C1O)C(=O)C3=C(C2=O)CCCC3)O |
| TCMBANKIN006987 | Gulutamine | 25513-46-6; G1251_SIGMA; Glutamic acid, L-, peptides; Acidum glutamicum; BPBio1_001132; L-Glutamic acid (9CI); AIDS071819; nchembio.2007.55-comp22; (S)-2-aminopentanedioic acid; L-Glutaminic acid; 26717-13-5; E 620; Biomol-NT_000170; Lopac0_000529; D00007; L-Glutamic acid, homopolymer (9CI); Poly(alpha-L-glutamic acid); NCGC00024502-01; (2S)-2-aminoglutaric acid; NCGC00024502-03; 24938-00-9; PDSP1_001539; L-Glutamic acid (JAN); W328502_ALDRICH; alpha-L-Glutamic acid polymer; HSCI1_000269; 09581_FLUKA; AIDS-071819; G5667_SIGMA; L-Glutaminsaeure; 49449_FLUKA; nchembio816-comp2; PDSP2_000127; Glutamic acid polymer; PDSP2_001523; alpha-Glutamic acid; G8415_SIGMA; C00025; 84960-48-5; Tocris-0218; CHEBI:16015; L-alpha-Aminoglutaric acid; PDSP1_000128; Glutamic acid, L- (7CI,8CI); (2S)-2-aminopentanedioic acid; POLYGLUTAMIC ACID; LS-2330; Gulutamine (USP) | C5H9NO4 | 147.13 g/mol | C(CC(=O)O)C(C(=O)O)N |
| TCMBANKIN007185 | dendroxine | C17H25NO3 | 291.4 g/mol | CC(C)C1C2C3CCC4C3(C5(C1OC2=O)N(C4)CCO5)C | |
| TCMBANKIN007708 | trans-4-hydroxyproline | trans-L-4-hydroxy-proline; trans-hydroxy-L-proline; CJ-04557; hydroxyproline zwitterion; trans-L-4-hydroxyproline; trans-4-hydroxy-L-proline zwitterion; (2S,4R)-4-hydroxypyrrolidin-1-ium-2-carboxylate; CHEBI:58375; AC1ODZ4B; (2S,4R)-4-hydroxypyrrolidinium-2-carboxylate; ZB015310; trans-oxyproline | C5H9NO3 | 131.13 g/mol | C1C(C[NH2+]C1C(=O)[O-])O |
| TCMBANKIN007905 | Acetol | Hydroxyacetone; Pyruvinalcohol; ZINC00895664; AI3-37788; Hydroxypropanone; 2-Propanone, 1-hydroxy-; 4-01-00-03977 (Beilstein Handbook Reference); BRN 0605368; WLN: Q1V1; Hydroxy-2-propanone; ACETYLCARBINOL; Acetone alcohol; 2-Oxopropanol; 2-Ketopropyl alcohol; 116-09-6; Pyruvic alcohol; ST5214599; 54142_FLUKA; 1-hydroxyacetone; 138185_ALDRICH; Methylketol; NSC 102497; 1-hydroxypropan-2-one; Methanol, acetyl-; C05235; NSC102497; EINECS 204-124-8; CHEBI:27957; 1-Hydroxy-2-propanone; Acetylmethanol; Hydroxymethyl methyl ketone | C3H6O2 | 74.08 | CC(=O)CO |
| TCMBANKIN008948 | glyceryl linolenate ii | [2-hydroxy-3-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate; AC1NSVZL | C39H68O5 | CCC=CCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC=CCC=CCC)O | |
| TCMBANKIN008994 | (Z)-3-(4-hydroxy-3,5-dimethoxy-phenyl)acrolein | (Z)-3-(4-hydroxy-3,5-dimethoxy-phenyl)prop-2-enal; (Z)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enal; 2-Propenal, 3-(4-hydroxy-3,5-dimethoxyphenyl), (Z)- | C11H12O4 | 208.21 | COC1=CC(=CC(=C1O)OC)C=CC=O |
| TCMBANKIN009017 | Threonin | 89179_FLUKA; 48: PN: WO2004076659 FIGURE: 7 claimed sequence; D00041; 13095-55-1; Threonine, L- (8CI); 7013-32-3; L-Threonin; (2S)-threonine; CHEBI:16857; Threonine (VAN); Treonina [Spanish]; THREONINE (L); Threoninum [Latin]; T8625_SIAL; Butanoic acid, 2-amino-3-hydroxy-, (R-(R*,S*))-; 36676-50-3; Threonine (USP); (2S,3R)-2-Amino-3-hydroxybutyric acid; Threonine, labeled with carbon-14, L-; C00188; L-(U-14C)Threonine; L-Threonine (JP15); 2-Amino-3-hydroxybutanoic acid, (R-(R*,S*))-; NSC 16589; T8441_SIGMA; (S)-Threonine; Threonine [USAN:INN]; L-Threonine (9CI); EINECS 200-774-1; threonin; L-alpha-amino-beta-hydroxybutyric acid; (2S,3R)-2-amino-3-hydroxybutanoic acid; [R-(R*,S*)]-2-Amino-3-hydroxybutanoic acid; NSC 46701; (2S,3R)-2-amino-3-hydroxy-butanoic acid; T4071_SIAL; (2S,3R)-2-amino-3-hydroxy-butyric acid | C4H9NO3 | 119.12 g/mol | CC(C(C(=O)O)N)O |
| TCMBANKIN009064 | PHA | alpha-Aminohydrocinnamic acid, L-; C00079; NSC-9959; nchembio816-comp8; NCGC00013103; P2126_SIAL; beta-phenylalanine; FEMA No. 3585; Phenylalaninum [Latin]; NSC 79477; (S)-2-Amino-3-phenylpropanoic acid; (S)-2-Amino-3-phenylpropionic acid; L-Alanine, 3-phenyl-; NCGC00095047-01; (L)-Phenylalanine; Phenylalanine (VAN); (S)-alpha-Aminohydrocinnamic acid; alpha-Amino-beta-phenylpropionic acid, L-; (S)-alpha-Amino-benzenepropanoic acid; NCIStruc1_000204; Phenylalanine [USAN:INN:JAN]; Phenylalanine (USP/INN); 2-Amino-3-phenylpropionic acid, L-; NCI9959; MTY; 67675-33-6; EINECS 200-568-1; alpha-aminohydrocinnamic acid; (2S)-2-amino-3-phenyl-propionic acid; L-Phenylalanine (JP15); W358509_ALDRICH; Fenilalanina [Spanish]; CCRIS 6767; CHEBI:17295; (2S)-2-amino-3-phenylpropanoic acid; L-PHENYLALININE; NCGC00095047-02; Benzenepropanoic acid, alpha-amino-, (S)-; beta-Phenylalnine, (-)-; Hydrocinnamic acid, alpha-amino-; P8740_SIAL; 10549-09-4; (2S)-2-amino-3-phenyl-propanoic acid; 5297-02-9; P5482_SIGMA; LS-1515; (S)-(-)-Phenylalanine; (S)-alpha-Amino-beta-phenylpropionic acid; HSDB 1825; NCIStruc2_000248; beta-Phenyl-L-alanine; ST5406159; D00021; 78019_FLUKA; Phenylalanine, L-; NCGC00095047-04 | C35H36N4O5 | 592.7 g/mol | CCC1=C(C2=NC1=CC3=C(C4=C(N3)C(=C5C(C(C(=CC6=NC(=C2)C(=C6C)C=C)N5)C)CCC(=O)O)C(=C4O)C(=O)OC)C)C |
| TCMBANKIN009495 | santene | (1R,4S)-2,3-Dimethylbicyclo[2.2.1]hept-2-ene | C9H14 | 122.21 g/mol | CC1=C(C2CCC1C2)C |
| TCMBANKIN009906 | cis-4-Hydroxy-L-proline | 56248_FLUKA; (2S,4S)-4-hydroxypyrrolidine-2-carboxylic acid; (2S,4S)-(−)-4-Hydroxy-2-pyrrolidinecarboxylic acid; C03441; (2S,4S)-4-hydroxy-2-pyrrolidinecarboxylic acid; (2S,4S)-4-hydroxyproline; 618-27-9; H1637_SIGMA | C5H9NO3 | 131.13 | C1C(CNC1C(=O)O)O |
| TCMBANKIN010088 | 16-episarpagine | SCHEMBL3082055 | C19H22N2O2 | 310.4 g/mol | CC=C1CN2C3CC1C(C2CC4=C3NC5=C4C=C(C=C5)O)CO |
| TCMBANKIN010410 | cis-4-hydroxyproline | 4-hydroxyproline; 4-cis-Hydroxy-L-proline; The (R)-4-hydroxy L-isomer has been assumedunless otherwise specified or implied in the original document and is indexed at L-Proline,4-hydroxy-,(4R)- [51-35-4]. When synthetichydroxyproline has been clearly indicated in theoriginal document,the 4-hydroxy; 4hydroxy-l-proline; AS-10781; L-Hydroxyproline; (2S)-4-hydroxypyrrolidine-2-carboxylic acid; (2S)-4-hydroxy-2-pyrrolidinecarboxylic acid; Proline, 4-allo-hydroxy-, L-; cis-Proline, 4-allo-hydroxy-, L-; I11-0279; 4 HYDROXYPROLINE; L-Proline, allo-hydroxy-; 30724-02-8; AC1Q5R4Z; cis-Hydroxyproline; L-4-Hydroxy-2-pyrrolidine-carboxylic acid; L-4-hydroxy-proline; L-Proline, allo-hydroxy-, cis; Proline, 4-hydroxy-; 4-Hydroxy-L-proline, (Z)-; SCHEMBL21184; L-Proline, 4-hydroxy-, cis-; TX-012051; 61748-69-4; cis-4-hydroxy-l-pro; 1599456-27-5; 4-Hydroxy-(L)-proline; AKOS030230112; A820581; CHEBI:18240; CTK5C9109; NSC 206274; BG00900691; (2S,4S)-(-)-4-Hydroxy-2-pyrrolidine carboxylic acid; (5S)-5-CARBOXY-3-HYDROXYPYRROLIDIN-3-YL; allo-L-Hydroxyproline; MolPort-003-990-096; PMMYEEVYMWASQN-BKLSDQPFSA-N; AC1L2BG7; (2S)-4-oxidanylpyrrolidine-2-carboxylic acid; allo-hydroxy-L-Proline; allo-4-Hydroxyproline; 4-Hydroxy-proline | C5H9NO3 | 131.13 g/mol | C1C(CNC1C(=O)O)O |
| TCMBANKIN010593 | homostephanoline | AC1LCF2Y; VCOZOQJXGDDART-UHFFFAOYSA-N; 3-Hydroxy-4,7,8-trimethoxy-17-methyl-7,8-didehydrohasubanan-6-one #; Homostephanoline | C20H25NO5 | 359.4 g/mol | CN1CCC23C1(CCC4=C2C(=C(C=C4)O)OC)C(=C(C(=O)C3)OC)OC |
| TCMBANKIN011400 | beta-santalol s | ||||
| TCMBANKIN013078 | nuciferol | C15H22O | 218.33 g/mol | CC1=CC=C(C=C1)C(C)CCC=C(C)CO | |
| TCMBANKIN013603 | beta-santalene e | ||||
| TCMBANKIN015145 | bisabolenol c | ||||
| TCMBANKIN015717 | tricyclokasantalal | ||||
| TCMBANKIN016117 | santalicacid | santalic acid | CC(=CCCC1(C2CC3C1(C3C2)C)C)C(=O)O | ||
| TCMBANKIN016565 | akebin d | ||||
| TCMBANKIN016670 | terminaline | AC1NT0UZ; (3S)-17-[1-(dimethylamino)ethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,4-diol | C23H41NO2 | 363.6 g/mol | CC(C1CCC2C1(CCC3C2CCC4C3(CCC(C4O)O)C)C)N(C)C |
| TCMBANKIN017447 | 2-Methylpentan-3-one | 04220_FLUKA; 2-METHYL-3-PENTANONE; InChI=1/C6H12O/c1-4-6(7)5(2)3/h5H,4H2,1-3H; EINECS 209-288-4; 108707_ALDRICH; 3-Pentanone, 2-methyl-; 565-69-5; Ethyl isopropyl ketone; 04222_FLUKA | C6H12O | 100.16 | CCC(=O)C(C)C |
| TCMBANKIN017750 | ketosantalicacid | C15H22O3 | 250.33 g/mol | CC(CC(=O)CC1(C2CC3C1(C3C2)C)C)C(=O)O | |
| TCMBANKIN018639 | N-Ethylpyrrole | Pyrrole, 1-ethyl-; ZINC01866964; 1-Ethylpyrrole; 617-92-5; 1H-Pyrrole, 1-ethyl-; NSC6756; 92933-61-4 | C6H9N | 95.14 | CCN1C=CC=C1 |
| TCMBANKIN019953 | lanceol | C15H24O | 220.35 g/mol | CC1=CCC(CC1)C(=C)CCC=C(C)CO | |
| TCMBANKIN020195 | (+)-Ledol | 577-27-5; C09698; 1H-Cycloprop(e)azulen-4-ol, decahydro-1,1,4,7-tetramethyl-, (1aR-(1aalpha,4alpha,4abeta,7alpha,7abeta,7balpha))- | C15H26O | 222.37 g/mol | CC1CCC2C1C3C(C3(C)C)CCC2(C)O |
| TCMBANKIN020690 | akebin c | ||||
| TCMBANKIN020794 | m-Picoline | 3-Picoline; m-Methylpyridine; NCGC00091447-01; .beta.-Picoline; beta-Picoline; 80230_FLUKA; 3-Mepy; HSDB 4254; NSC 18251; 3-Methyl pyridine; 236276_ALDRICH; Pyridine, 3-methyl-; NSC18251; CCRIS 1722; 82005-08-1; 3-Methylpyridine; AI3-24110; .beta.-Methylpyridine; InChI=1/C6H7N/c1-6-3-2-4-7-5-6/h2-5H,1H; EINECS 203-636-9; 108-99-6; 61204-14-6; m-Picoline [UN2313] [Flammable liquid]; CHEBI:39922; NCIOpen2_004641; beta-Methylpyridine; P42053_ALDRICH; 3-Pyridylmethyl radical | C6H7N | 93.13 | CC1=CN=CC=C1 |
| TCMBANKIN021049 | bisabolenol e | ||||
| TCMBANKIN021297 | PHYTANTRIOL | phytantriol | C20H42O3 | 330.55 | CC(C)CCCC(C)CCCC(C)CCCC(C)(C(CO)O)O |
| TCMBANKIN022040 | dendrolasin | Furan, 3-(4,8-dimethyl-3,7-nonadienyl)-, (E)-; 3-[(3E)-4,8-dimethylnona-3,7-dien-1-yl]furan; C16779; CHEBI:80721; 3-(4,8-Dimethyl-3,7-nonadienyl)furan, 9CI; LZBXPXAOYQVZEC-RIYZIHGNSA-N; 3-[(3E)-4,8-dimethylnona-3,7-dienyl]furan; 3-(4,8-Dimethyl-3,7-nonadienyl)-Furan; (e)-3-(4,8-dimethyl-3,7-nonadienyl)-furan; AKOS015905136; I14-21952; 3-[(3E)-4,8-Dimethyl-3,7-nonadienyl]furan; 3-[(3E)-4,8-dimethyl-nona-3,7-dienyl]-furan; Denderalasin; Dendrolasin; SCHEMBL11886113; 3-(4,8-Dimethyl-3,7-nonadienyl)-(E)-Furan; I14-23360; Dendrasaline; AC1NSUDB; Furan, 3-(4,8-dimethyl-3,7-nonadienyl)-; 23262-34-2; 3-[(3E)-4,8-Dimethyl-3,7-nonadienyl]furan #; 3-(4,8-Dimethyl-3,7-nonadienyl)furan | C15H22O | 218.33 g/mol | CC(=CCCC(=CCCC1=COC=C1)C)C |
| TCMBANKIN023212 | bisabolenol b | ||||
| TCMBANKIN023497 | e-nuciferol | 218.37 | |||
| TCMBANKIN024913 | akebin a | ||||
| TCMBANKIN025338 | akebin g | ||||
| TCMBANKIN026017 | h-Met-h | L-2-Amino-4methylthiobutyric acid; (2S)-2-amino-4-(methylthio)butanoic acid; NSC 22946; Methionine (USP); L-Methionine Z (TN); 2-Amino-4-methylthiobutanoic acid (S)-; L-Methionine-35S; Metionina [DCIT]; 24425-78-3; h-Met-oh; M9625_SIAL; (S)-methionine; nchembio816-comp7; Acimethin; (35S)Methionine; S-Methyl-L-homocysteine; Toxin WAR (Bacillus thuringiensis strain PS205C); Soft tissue sarcoma-associated protein (human clone WO2004048938-SEQID-1139); M8439_SIAL; (L)-Methionine; (2S)-2-amino-4-(methylthio)butyric acid; 3654-96-4; 64319_FLUKA; L-Methionine Z; 58576-49-1; EINECS 200-562-9; NCGC00160620-01; (S)-(+)-Methionine; (2S)-2-amino-4-methylsulfanylbutanoic acid; C00073; C-11 Met; Poly-L-methionine; Polymethionine; L-Homocysteine, S-methyl-; HSDB 4317; L-alpha-Amino-gamma-methylmercaptobutyric acid; D00019; CCRIS 5536; L-gamma-Methylthio-alpha-aminobutyric acid; L-Methionine, labeled with carbon-11; (S)-2-amino-4-(methylthio)butyric acid; NSC 118113; nchembio.2007.56-comp4; gamma-Methylthio-alpha-aminobutyric acid; Methionine [USAN:INN]; L-Methioninum; carbon-11 methionine; (S)-2-Amino-4-(methylmercapto)butyric acid; CCRIS 5528; 26062-47-5; C-11 Methionine; Methionine (VAN); (2S)-2-amino-4-methylsulfanyl-butanoic acid; (2S)-2-amino-4-(methylsulfanyl)butanoic acid; (S)-2-Amino-4-(methylthio)butanoic acid; Methionine C 11; 2-Amino-4-(methylthio)butyric acid, (S)-; Liquimeth; Methioninum [INN-Latin]; L-2-Amino-4-(methylthio)butanoic acid; Methionine, L- (8CI); L(-)-Amino-gamma-methylthiobutyric acid; L-Methionin; InChI=1/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8; CHEBI:16643; M5308_SIGMA; L-Methionine, homopolymer; L-Methionine (JP15); L-alpha-Amino-gamma-methylthiobutyric acid | C5H11NO2S | 149.21 g/mol | CSCCC(C(=O)O)N |
| TCMBANKIN027607 | β-santalicacid | CC(C=CCC1(C2CCC(C2)C1=C)C)C(=O)O | |||
| TCMBANKIN027974 | L-Lysin | AI3-26523; h-Lys-oh; 3H-Lysine; EINECS 200-294-2; Lysine, L-; 20166-34-1; 48050-57-3; 2,6-Diaminohexanoic acid, (S)-; Hydrolysine; Lysine homopolymer, L-; Lysinum [Latin]; (S)-2,6-Diaminocaproic acid; Gidrolizin; L-Lysine, homopolymer; 280114-50-3; D02304; L5501_SIGMA; 12798-06-0; nchembio861-comp2; LYS (IUPAC abbreviation); Polylysine; 4-04-00-02717 (Beilstein Handbook Reference); (2S)-2,6-diaminohexanoic acid; L-Lysine, labeled with tritium; (S)-Lysine; (S)-alpha,epsilon-Diaminocaproic acid; L-103; L-Norleucine, 6-amino-; W384704_ALDRICH; Lisina [Spanish]; Aminutrin; alpha-Lysine; (2S)-2,6-Diamino-hexanoic acid; (S)-2,6-diaminohexanoic acid; 25104-18-1; CHEBI:18019; L9037_SIGMA; Hexanoic acid, 2,6-diamino-, (S)-; Hydrolysin; 62840_FLUKA; C00047; BRN 1722531; 6899-06-5; HSDB 2108; Lysine [USAN:INN]; Lysine (USAN); 26714-32-9 | C6H12N2O | 128.17 g/mol | C(CCN)C[CH+]C(=O)[NH-] |
| TCMBANKIN029584 | sym-homospermidine | N-(4-azaniumylbutyl)butane-1,4-bis(aminium); CHEBI:57811; sym-homospermidinium(3+); sym-homospermidinium trication | C8H21N3 | 159.27 g/mol | C(CCNCCCCN)CN |
| TCMBANKIN030524 | Methylpyrrole | EINECS 202-513-7; NSC 65440; NSC65440; MR3; M78801_ALDRICH; 69100_FLUKA; 96-54-8; InChI=1/C5H7N/c1-6-4-2-3-5-6/h2-5H,1H; ZINC01692446; 1-Methylpyrrole; CCRIS 2934; W509973_ALDRICH; N-Methylpyrrole; 1-methyl-1H-pyrrole; 1H-Pyrrole, 1-methyl-; Pyrrole, 1-methyl- | C5H7N | 81.12 | CN1C=CC=C1 |
| TCMBANKIN031136 | Leucinum | polyleucine; (S)-2-Amino-4-methylpentanoic acid; Leucine (H-3); 71000-80-1; 2-Amino-4-methylpentanoic acid (L); L-Norvaline, 4-methyl-; Leucina [Latin,Spanish]; NCI46709; L8912_SIGMA; (2S)-2-amino-4-methyl-pentanoic acid; L-Leucine, homopolymer; (14C)Leucine, L-; L-2-Amino-4-methylpentanoic acid; 2-Amino-4-methylvaleric acid (L); Leucine (USP); (2S)-2-amino-4-methylpentanoic acid; Leucine [USAN:INN]; InChI=1/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s; FEMA No. 3297; Leucina [INN-Spanish]; L-Leucine, labeled with tritium; C00123; Leucine (VAN); l-(14C)Leucine; 21675-61-6; 25248-98-0; L8000_SIGMA; (S)-2-Amino-4-methylvaleric acid; NSC-46709; (3H)Leucine; (2S)-2-amino-4-methyl-valeric acid; L-Leucin; 2-Amino-4-methyl-valeric acid; W329703_ALDRICH; L-alpha-Aminoisocaproic acid; L6914_SIAL; NCIStruc1_001860; NCIStruc2_000010; (S)-2-Amino-4-methyl-pentanoic acid; L-Leuzin; NCGC00013565; 14C-Leucine; L-Leucine (JP15); Poly(L-leucine); (S)-Leucine; Valeric acid, 2-amino-4-methyl-, (S)-; L-Leucine, labeled with carbon-14; CHEBI:15603; NSC 46709; 72706_FLUKA; D00030; AI3-08899; Leucinum [INN-Latin]; 61819_FLUKA; 70-45-1; alpha-aminoisocaproic acid; EINECS 200-522-0; Leucin [German]; 2-Amino-4-methylpentanoic acid, (S)- | C6H13NO2 | 131.17 g/mol | CC(C)CC(C(=O)O)N |
| TCMBANKIN031636 | Pymadin | KBioSS_000282; CHEBI:34385; Lopac0_000032; Caswell No. 038; 4-Pyridylamine; KBio2_002850; SPBio_001486; Spectrum4_001013; Lopac-A-0152; [J.Pharmacol.Exp.Ther. 275:864 (1995)]; SPECTRUM1501130; KBio2_000282; Bio2_000282; KBio1_000572; Avitrol 200; gamma-Aminopyridine; KBio2_005418; KBioSS_000635; NSC 15041; C13728; A106; NCGC00024890-07; KBio3_000564; Philips 1861; KBio2_003203; KBio2_005771; Spectrum2_001413; p-Aminopyridine; EPA Pesticide Chemical Code 069201; KBio2_000635; Spectrum5_001501; AIDS020431; IDI1_000572; Tocris-0940; AI3-52547; Compound 1861; Pimadin (free base); NCGC00024890-04; HSDB 6037; 4 AP; RCRA waste no. P008; Bio1_000353; 4-AP; .gamma.-Aminopyridine; UPCMLD-DP125:001; Mi-W-3; NINDS_000572; KBioGR_000282; NCGC00024890-08; KBio3_001888; SBB004393; p-Aminopyridine [UN2671] [Poison]; KBio3_000563; BRN 0105782; SMR000058211; Amino-4 pyridine; EU-0100032; Fampridine (USAN); Neurelan (TN); NCGC00024890-05; Bio2_000762; Fampridine-SR; 504-24-5; Bio1_000842; A78403_ALDRICH; AIDS-020431; IDI1_034032; D04127; NCGC00024890-09; WLN: T6NJ DZ; VMI 10-3; 275875_ALDRICH; Spectrum3_000914; InChI=1/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7; Avitrol; AMINOPYRIDINE; DivK1c_000572; 4-Aminopyridine; Fampridine [USAN:INN]; EINECS 207-987-9; Spectrum_000155; Neurelan; KBioGR_001505; Bio1_001331; Fampridine; EL-970; NCGC00024890-03; BSPBio_001562; AC-907/25014071; 36687_RIEDEL; Ampydin; PYRIDINE,4-AMINO; 4-Pyridinamine; VMI-10-3; pyridin-4-amine; NCGC00024890-01; Phillips 1861; SDCCGMLS-0066228.P001; Prc 1237; MLS000069400; 5-22-09-00106 (Beilstein Handbook Reference); NCGC00015009-01; NSC15041; Pyridine, 4-amino- | C5H6N2 | 94.11 | C1=CN=CC=C1N |
| TCMBANKIN031750 | norarjunolicacid-28-o-α-l-rhammnosyl(1→4)-β-d-glucosyl(1→6)-β-d-glucopyranoside | ||||
| TCMBANKIN032467 | (1S,4R)-2,3-dimethylbicyclo[2.2.1]hept-2-ene | C9H14 | 122.21 | ||
| TCMBANKIN033165 | 2-Methylpenta-1,3-diene | EINECS 214-264-1; 1,3-pentadiene, 2-methyl-, (3E)-; 1,3-Pentadiene, 2-methyl-, (E)-; EINECS 213-136-2; (E)-CH2=C(CH3)CH=CHCH3; 926-54-5; 2,4-Dimethyl-1,3-butadiene; NSC 123452; InChI=1/C6H10/c1-4-5-6(2)3/h4-5H,2H2,1,3H3/b5-4; trans-2-Methylpenta-1,3-diene; 1118-58-7; 1,3-Pentadiene, 2-methyl-; 2-METHYL-1,3-PENTADIENE; NSC123452; 1,3-Dimethyl-1,3-butadiene; (3E)-2-methylpenta-1,3-diene | C6H10 | 82.14 | CC=CC(=C)C |
| TCMBANKIN033758 | hederagenin-3-o-β-d-xyl(1→3)-α-l-arabino-pyranoside | C40H64O12 | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)OC6C(C(C(CO6)O)OC7C(C(C(CO7)O)O)O)O)C)C)C2C1)C)C(=O)O)C | ||
| TCMBANKIN033812 | bisabolenol a | ||||
| TCMBANKIN035813 | beta-santalene s | ||||
| TCMBANKIN036420 | santenone | 4,7-dimethylbicyclo[2.2.1]heptan-3-one; 2-cyclopropyl-6-isopropylphenyl methoxymethyl ether; 7492-82-2; 20529-87-7; 1,7-dimethylbicyclo[2.2.1]heptan-2-one; AC1NT07C | C9H14O | 138.21 | CC1C2CCC1(C(=O)C2)C |
| TCMBANKIN036837 | vitexin | 49513_FLUKA; vitexin ; vitexin-7-olate anion; Flavone, 8-D-glucosyl-4',5,7-trihydroxy-; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]chromone; vitexin-7-olate; vitex-in; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one; 8-beta-D-Glucopyranosyl-apigenin; 521-33-5; CHEBI:16954; 8-beta-D-Glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Vitexin; vitexin-7-olate(1-); 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]-4-chromenone; Apigenin 8-C-glucoside; 8C-hexosyl apigenin; (1S)-1,5-anhydro-1-[5-hydroxy-2-(4-hydroxyphenyl)-7-oxido-4-oxo-4H-chromen-8-yl]-D-glucitol; CHEBI:57963; (1S)-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-D-glucitol; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-beta-D-glucopyranosyl-2-(4-hydroxyphenyl)-; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-.beta.-D- glucopyranosyl-2-(4-hydroxyphenyl)-; 8-C-beta-glucopyranosylapigenin; 4H-1-Benzopyran-4-one, 8-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-; NCGC00163642-01; C01460; EINECS 222-963-8; 5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one; vitexin anion; 3681-93-4; AIDS026705; AIDS-026705 | C21H20O10 | 432.378 | c1([H])c(C2=C([H])C(c3c(c([C@]4([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]4([H])O[H])c(O[H])c([H])c3O[H])O2)=O)c([H])c([H])c(O[H])c1[H] |
| TCMBANKIN036901 | myristic acid | 1-Tridecanecarboxylic acid; Myristinsaeure; CH3-[CH2]12-COOH; 70079_FLUKA; AI3-15381; LMFA01010014; CH3-[CH2]12-COO(-); NCGC00091068-02; Myristic acid-[9,10-3H]; C06424; Emery 655; myristic acid ; NSC 5028; 70082_FLUKA; C14 fatty acid; ST023797; W276405_ALDRICH; CCRIS 4724; Kortacid 1499; 3uev; TUNFSRHWOTWDNC-UHFFFAOYSA-M; Tetradecanoic acid; EINECS 250-924-5; n-Tetradecoic acid; 4-02-00-01126 (Beilstein Handbook Reference); Hydrofol acid 1495; MYR; BRN 0508624; Myristate; Myristic acid (natural); Tetradecanoate; LS-190125; Crodacid; Myristic acid (8CI); EINECS 208-875-2; Prifac 2942; Myristic acid; AIDS002505; tetradecoate; W276413_ALDRICH; FEMA No. 2764; HSDB 5686; Philacid 1400; CHEBI:28875; Edenor C 14; n-tetradecoate; 45184-05-2; myristicacid; tetradecoic acid; n-Tetradecanoic acid; M3128_SIGMA; AIDS-002505; Univol U 316S; Lead dimyristate; AC1N2PSK; NCGC00091068-01; neo-Fat 14; NSC5028; Tetradecanoic acid (9CI); Hystrene 9014; Myristic acid, pure; M4792_SIGMA; CHEBI:30807; n-Tetradecan-1-oic acid; WLN: QV13; 1-tetradecanecarboxylate; 32112-52-0; n-tetradecan-1-oate; 544-63-8 | C14H28O2 | 228.371 | C([H])([H])(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] |
| TCMBANKIN036904 | isovitexin | beta-D-isovitexin; LMPK12110338; Iso Vitexin; CHEBI:18330; 61383-34-4; C01714; 61838-34-4; 29702-25-8; 6-beta-D-Glucopyranosyl-4',5,7-trihydroxyflavone; 4H-1-Benzopyran-4-one, 6-beta-D-glucopyranosyl-5,7- dihydroxy-2-(4-hydroxyphenyl)-; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]-4-chromenone; 6-Glucosylapigenin; Isovitexin; Apigenin-6-C-glucoside; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]chromone; Apigenin 6-C-glucoside; 38953-85-4; NCGC00163578-01; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one; Saponaretin; 4H-1-Benzopyran-4-one, 6-beta-D-glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)- (VAN); AIDS339232; (1S)-1,5-anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-6-yl]-D-glucitol; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one; 6-C-Glucosylapigenin; AIDS-339232 | C20H18O10 | 418.351 | c1(C2=C([H])C(=O)c(c(O[H])c([C@@]3([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])O3)c(O[H])c4[H])c4O2)c([H])c([H])c(O[H])c([H])c1[H] |
| TCMBANKIN036917 | apigenin | 520-36-5; Spectrum2_000428; 10798_FLUKA; Biochem Biophys Res Comm 212: 767 (1997); CCRIS 3789; AIDS001401; apigenin-7-olate; KBioGR_002565; KBio3_002887; BSPBio_000368; 5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; HSCI1_000221; Flavone, 4',5,7-trihydroxy-; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-; EINECS 208-292-3; A3145_SIGMA; 7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-1-benzopyran-5-olate; CHEBI:18388; IDI1_000798; NCGC00025057-04; AIDS-001401; NSC 83244; BPBio1_000406; Apigenol; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromenone; NINDS_000798; NCGC00015049-02; 4′,5,7-Trihydroxyflavone; SPBio_002307; Prestwick_719; 2-(4-hydroxyphenyl)-7-oxidanyl-4-oxidanylidene-chromen-5-olate; Spectrum4_001999; Chamomile; KBio1_000798; BRN 0262620; Prestwick2_000414; Prestwick3_000414; SDCCGMLS-0066379.P001; CHEBI:58470; 5,7, 4'-trihydroxyflavone; NCGC00025057-02; 2-(p-Hydroxyphenyl)-5,7-dihydroxychromone; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; APIGENIN; Lopac0_000065; K00045; 4′,5,7-Trihydroxyflavone; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone; NCGC00025057-09; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; ACon1_002450; Oprea1_622293; EU-0100065; nchembio790-comp26; 4',5,7-Trihydroxyflavone; NCGC00025057-08; ND-9076; NCGC00025057-01; MEGxp0_000176; Apigenin; 4',5,7-Trihydroxyflavone; apigenin ; Prestwick1_000414; NCGC00015049-01; ZINC00004495; NCGC00025057-05; Spectrum3_001882; BiomolKI_000078; NCI60_041830; Bio1_001354; ghl.PD_Mitscher_leg0.1194; SPECTRUM200846; A828903; DivK1c_000798; 5-18-04-00574 (Beilstein Handbook Reference); 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate; C.I. Natural Yellow 1; 461015-54-3; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)- (9CI); 5,7-dihydroxy-2-(4-hydroxyphenyl)chromone; SMP2_000338; BiomolKI2_000082; Prestwick0_000414; Tocris-1227; Lopac-A-3145; Bio1_000865; NSC83244; Versulin; Pelargidenon 1449; Bio1_000376; Spigenin; 5,7,4'-Trihydroxyflavone; ST056301; UCCF 031; SPBio_000416; Apigenine; C01477; CAS-520-36-5; BSPBio_003384 | C15H10O5 | 270.24 | C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O |
| TCMBANKIN037090 | α-Hederin | alpha-hederin ; alpha-hederin | 751 g/mol | ||
| TCMBANKIN037277 | Oleanolic acid | Olean-12-en-28-oic acid, 3.beta.-hydroxy-; s2334; Caryophyllin; AIDS014809; Giganteumgenin C; SMR000445561; oleanolicacid; (3-beta)-3-Hydroxyolean-12-en-28-oic acid; AIDS-014809; Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-; EINECS 208-081-6; NSC 114945; OLEANOLIC ACID; Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-; CCRIS 6493; AS-11663; SCHEMBL1699365; Virgaureagenin B; CHEBI:37659; MLS000697656; (4aS,5S,6aS,6bR,8R,8aR,10S,12aR,12bR,14bS)-10-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid; AKOS022168208; O5504_SIGMA; MolPort-016-633-333; Oleanolic Acid; Olean-12-en-28-oic acid, 3-beta-hydroxy- (8CI); Oleanic acid; 3beta-Hydroxyolean-12-en-28-oic acid; 3-beta-Hydroxyolean-12-en-28-oic acid; ST057162; Olean-12-en-28-oic acid, 3beta-hydroxy- (8CI); NSC114945; Oleanolic Acid (Caryophyllin); Astrantiagenin C; Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-; 508-02-1; (4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picene-4-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; oleanolic acid | C30H48O3 | 457 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(=O)O[H])C([H])([H])C3([H])[H])[C@@]34C( [H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
| TCMBANKIN038028 | β-Santalal | beta-santalal | 218.33 g/mol | ||
| TCMBANKIN038399 | α-Santalene | ZINC64634147; alpha-santalene ; ZINC100506743; (+)-alpha-santalene; alpha-santalene; (1S,2R,4S,6R,7R)-1,7-dimethyl-7-(4-methylpent-3-en-1-yl)tricyclo[2.2.1.0(2,6)]heptane; KWFJIXPIFLVMPM-PEGGXJLSSA-N; CHEBI:61677; (2R,6S,7R)-1,7-DIMETHYL-7-(4-METHYLPENT-3-EN-1-YL)TRICYCLO[2.2.1.0(2),?]HEPTANE | 204.35 | ||
| TCMBANKIN038691 | γ-L-Glutamyl-S-(prop-1-enyl)cystein sulfoxide | ||||
| TCMBANKIN038975 | gamma-Glutamyl-serine | 2-amino-5-[(1,3-dihydroxy-1-oxopropan-2-yl)amino]-5-oxopentanoic acid; AC1NSVYR | C8H14N2O6 | 234.207 | O([H])C(=O)[C@]([H])(N([H])[H])C([H])([H])C([H])([H])C(=O)N([H])[C@]([H])(C([H])([H])O[H])C(=O)O[H] |
| TCMBANKIN038985 | 10(E)-beta-Santalic acid | (E)-2-methyl-5-[(1S,4R,6R)-6-methyl-5-methylidene-6-bicyclo[2.2.1]heptanyl]pent-2-enoic acid; InChI=1/C15H22O2/c1-10(14(16)17)5-4-8-15(3)11(2)12-6-7-13(15)9-12/h5,12-13H,2,4,6-9H2,1,3H3,(H,16,17)/b10-5+/t12-,13?,15?/m1/s; (E)-2-methyl-5-[(1S,2R,4R)-2-methyl-3-methylene-norbornan-2-yl]pent-2-enoic acid; (E)-2-methyl-5-[(1S,2R,4R)-2-methyl-3-methylene-2-norbornanyl]pent-2-enoic acid | C15H22O2 | 234.334 | C1([H])([H])C([H])([H])[C@@]2([H])C([H])([H])[C@]1([H])C(=C([H])[H])[C@]2(C([H])([H])[H])C([H])([H])C([H])([H])\C([H])=C(\C(O[H])=O)/C([H])([H])[H] |
| TCMBANKIN038989 | β-santalene | BETA-SANTALENE; (-)-beta-Santalene; CHEBI:10440; (1S-exo)-2-methyl-3-methylene-2-(4-methyl-3-pentenyl)bicyclo[2.2.1]heptane; (-)-ss-Santalen; beta-santalene; C09718; 511-59-1; PGBNIHXXFQBCPU-ILXRZTDVSA-N; (1S,2R,4R)-2-methyl-3-methylidene-2-(4-methylpent-3-en-1-yl)bicyclo[2.2.1]heptane | C15H24 | 204.35 g/mol | CC(=CCCC1(C2CCC(C2)C1=C)C)C |
| TCMBANKIN039243 | CPB-53-641-1 | ||||
| TCMBANKIN039722 | orientin | 28608-75-5; Orientin; CHEBI:7781; luteolin-8-C-beta-D-glucopyranoside; Lutexin; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]-4-chromenone; AIDS026706; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-8-beta-D-glucopyranosyl-5,7-dihydroxy-; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]chromone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one; Luteolin 8-C-glucoside; 2-(3,4-dihydroxyphenyl)-8-beta-D-glucopyranosyl-5,7-dihydroxy-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one; 8-beta-D-glucosylluteolin; 2-(3,4-Dihydroxyphenyl)-8-beta-D-glucopyranosyl-5,7-dihydroxy-4H-1-benzopyran-4-one; C10114; LMPK12110470; AIDS-026706; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-8-.beta.-D-glucopyranosyl-5,7-dihydroxy-; Orientin (Flavone); Luteolin 8-C-beta-D-glucopyranoside; Luteolin 8-glucoside; 8-beta-D-Glucopyranosyl-3',4',5,7-tetrahydroxyflavone | C21H20O11 | 448.38 | C1=CC(=C(C=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)C4C(C(C(C(O4)CO)O)O)O)O)O |
| TCMBANKIN041373 | 7S,8S-nitidanin | C21H24O8 | 404.41 | c1(\C([H])=C([H])\C([H])([H])O[H])c([H])c(O[C@@]([H])(c2c([H])c(OC([H])([H])[H])c(O[H])c(OC([H])([H])[H])c2[H])[C@@]([H])(O3)C([H])([H])O[H])c3c(OC([H])([H])[H])c1[H] | |
| TCMBANKIN042260 | Teresantalol | Tricyclo[2.2.1.0(2,6)]heptane-3-methanol, 2,3-dimethyl-; 2,3-Dimethyltricyclo[2.2.1.02,6]heptane-3-methanol; {2,3-DIMETHYLTRICYCLO[2.2.1.0(2),?]HEPTAN-3-YL}METHANOL; ZWUWJJHLJNLVDD-UHFFFAOYSA-N; 10-hydroxytricyclene; AKOS024262936; 2,3-Dimethyltricyclo[2.2.1.02,6]heptane-3-methanol, 9CI; {2,3-dimethyltricyclo[2.2.1.0;{2,6}]heptan-3-yl}methanol; 2,3-Dimethyl-Tricyclo[2.2.1.0(2,6)]heptane-3-methanol; Tricyclo[2.2.1.0(2,6)]heptane-3-methanol, 2,3-dimethyl-, stereoisomer; AC1LB8D4; Teresantalol; 29550-55-8; CTK8A1990 | 152.23 g/mol | ||
| TCMBANKIN042858 | Luteolin | Prestwick3_000870; TNP00073; 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate luteolin-7-olate(1-); 62696_FLUKA; ACon1_000223; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-chromenone; Digitoflavone; SMR000326896; luteolin-7-olate anion; 4H-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; CHEBI:57545; FLAVONE, 3',4',5,7-TETRAHYDROXY-; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-benzopyrone; A827664; BPBio1_001011; MEGxp0_000143; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy- (9CI); Weld Lake; BSPBio_000919; CHEBI:15864; 2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-olate; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one; Oprea1_849964; Yama kariyasu; 4-[5,7-bis(oxidanyl)-4-oxidanylidene-chromen-2-yl]-2-oxidanyl-phenolate; ST024703; luteolin ; NCGC00016467-02; EINECS 207-741-0; AIDS001406; NCGC00142375-02; C.I. Natural Yellow 2; S00110; Luteoline; Luteolin; Luteolol; 3′,4′,5,7-Tetrahydroxyflavone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; Prestwick_122; 5,7,3',4'-Tetrahydroxyflavone; BRN 0292084; CAS-491-70-3; 4-(5,7-dihydroxy-4-oxo-1-benzopyran-2-yl)-2-hydroxyphenolate; ZINC00008613; NCGC00142375-01; Prestwick1_000870; AIDS-001406; C01514; CCRIS 3790; 3',4',5,7-Tetrahydroxyflavone; Flacitran; Cyanidenon 1470; MLS000697655; SPBio_002840; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one; Lopac0_000660; NCGC00016467-01; C.I. 75590; Prestwick0_000870; 491-70-3; 2-(3,4-Dihydroxyphenyl)-5-hydroxy-7-oxylato-4H-1-benzopyran-4-one; 5-18-05-00296 (Beilstein Handbook Reference); Prestwick2_000870; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one; L9283_SIGMA; 3′,4′,5,7-Tetrahydroxyflavone; SMP2_000042; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromone | C15H10O6 | 286.236 | c1(O[H])c([H])c(OC(c2c([H])c([H])c(O[H])c(O[H])c2[H])=C([H])C3=O)c3c(O[H])c1[H] |
| TCMBANKIN044370 | Santlic acid | C15H22O2 | 234.334 | C([H])([H])([H])\C(\C(O[H])=O)=C([H])\C([H])([H])C([H])([H])[C@@]1(C2(C([H])([H])[H])[C@]([H])([C@@]2([H])C3([H])[H])C([H])([H])C13[H])C([H])([H])[H] | |
| TCMBANKIN045100 | Diethylene glycol monobenzoate | AC1Q68DL; Diethylene glycol monobenzoate; UNII-U8NT2B98P1; Ethanol, 2,2'-oxybis-, monobenzoate; KB-76835; NSC-71576; LS-181644; AI3-13034; DNUPYEDSAQDUSO-UHFFFAOYSA-N; AN-18532; Ethanol,2-[2-(benzoyloxy)ethoxy]-; 2-(2-Hydroxyethoxy)ethyl benzoate; U8NT2B98P1; AK545223; Ethanol, 2-(2-(benzoyloxy)ethoxy)-; Diethylene glycol benzoate; 20587-61-5; NSC 71576; ACM20587615; TRA0021031; CJ-06603; Diethylene glycol, monobenzoate; Diethylene glycol monobenzoate; 2,2-(Benzoyloxy)ethoxy-ethanol; NSC71576; MolPort-006-123-309; NCIOpen2_003520; AKOS024257968; SCHEMBL818564; Ethanol, 2-[2-(benzoyloxy)ethoxy]-; 3-Oxa-1,5-pentanediol 1-benzoate; Ethanol,2'-oxybis-, monobenzoate; ZINC1696992; EINECS 243-895-5; AC1L3G2X; DTXSID6041921 | 210.226 | ||
| TCMBANKIN045476 | vicenin-2 | 5,7,4'-Trihydroxyflavone-6,8-di-C-glucoside; MLS000575019; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one; Apigenin-6,8-di-C-glycoside; SMR000232371; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]-4-chromenone; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]chromone; C10195; vicenin- 2; 23666-13-9; vicenin-2; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one | C27H30O15 | 595 | c1([C@]2([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]2([H])O[H])c(O[H])c(C(=O)C([H])=C(c3c([H])c([H])c(O[H])c([H])c3[H])O4)c4c([C@]5([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[ H])[C@]([H])(O[H])[C@@]5([H])O[H])c1O[H] |
| TCMBANKIN046408 | isoorientin | isoorientin 7-olate; isoorientin(1-); Isoorientin; AIDS-026707; 2-(3,4-Dihydroxyphenyl)-6-beta-D-glucopyranosyl-5,7-dihydroxy-4H-1-benzopyran-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-6-beta-D-glucopyranosyl-5,7-dihydroxy-; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]-4-chromenone; C01821; NCGC00163566-01; (1S)-1,5-anhydro-1-[2-(3,4-dihydroxyphenyl)-5-hydroxy-7-oxido-4-oxo-4H-chromen-6-yl]-D-glucitol; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one; 4261-42-1; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]chromone; AIDS026707; CHEBI:58333; CHEBI:17965; (1S)-1,5-anhydro-1-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-6-yl]-D-glucitol; 6C-hexosyl luteolin; Homoorientin; isoorientin anion; isoorientin ; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one; Luteolin 6-C-glucoside | C21H20O11 | 448.377 | c12c(OC(c3c([H])c([H])c(O[H])c(O[H])c3[H])=C([H])C1=O)c([H])c(O[H])c([C@@]4([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O4)c2O[H] |
| TCMBANKIN057923 | glycin | Tocris-0219; G5417_SIGMA; WLN: Z1VQ; LS-218; 56-40-6; Glycosthene; G7126_SIGMA; Hgly; Glycine-UL-14C hydrochloride; EINECS 200-272-2; Padil; Polyglycine II; AB-131/40217813; Acido aminoacetico [INN-Spanish]; Glycine [INN]; G7403_SIGMA; CCRIS 5915; GLY (IUPAC abbrev); W328707_ALDRICH; Glycine-2-3H; G3649_SIGMA; InChI=1/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5; Glycine iron sulphate (1:1); NSC 25936; P8791_SIGMA; Leimzucker; Gyn-Hydralin; D00011; Aminoessigsaeure; 50046_FLUKA; Acidum aminoaceticum [INN-Latin]; Aminoethanoic acid; aminoacetic acid; AI3-04085; 33242-26-1; H2N-CH2-COOH; C00037; G8898_SIGMA; Glyzin; G0398_SIGMA; Amitone; Hampshire glycine; Glycocoll; G5523_SIGMA; Acide aminoacetique [INN-French]; Glycine-carboxy-14C hydrochloride; Glicina [INN-Spanish]; Glycinum [INN-Latin]; Glykokoll; ST5213923; 15527_RIEDEL; 7490-95-1; NChemBio.2007.13-comp1; Glycine, non-medical; BPBio1_001222; Biomol-NT_000195; 57678-19-0; Glycolixir; 63183-41-5; 87867-94-5; HSDB 495; AIDS071643; FEMA No. 3287; CHEBI:15428; 33226_RIEDEL; Sucre de gelatine; 17829-66-2; 410225_SIAL; NCGC00024503-01; 2-Aminoacetic acid; Aminoazijnzuur; NSC25936; Glycine (JP15/USP); polyglycine; 52955-63-2; carbonocyanidic acid; 32817-15-5; 2-aminoethanoic acid; Aciport; L-Glycine; Glicoamin; 25718-94-9; Acetic acid, amino-; G8790_SIGMA; AIDS-071643; NCGC00024503-02; Glycine, homopolymer (VAN); glycine;CHEMBL451140; N'-[N-(2a,3b-Dihydroxy-12-oleanen-28-oyl)-L-alanyl]-glycine; 2-[[(2S)-2-[[(4aS,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carbonyl]amino]propanoyl]amino]acetic acid;GLY | C2H5NO2 | 75.07 g/mol | C(C(=O)O)N |
| TCMBANKIN057929 | serine | (s)-serine;H-Ser; Serinum [Latin]; 56-45-1; SCHEMBL1775; L-Serine, Vetec(TM) reagent grade, >=99%; bmse000867; (2S)-2-amino-3-hydroxypropanoic acid; Serine (L-Serine); EC 200-274-3; 6898-95-9; CS-W020136; L-Serine, homopolymer; CHEBI:17115; H-Ser-OH; S0035; L-Serine, PharmaGrade, Ajinomoto, EP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture; 2-Amino-3-hydroxypropanoic acid-, (S)-; b-Hydroxy-L-alanine; Propanoic acid, 2-amino-3-hydroxy-, (S); L-2-Amino-3-hydroxypropanoic Acid; BRN 1721404; EBD2198140; BC676679; Serinum; Serine (VAN); L-Serine;; NSC760115; (S)-(-)-Serine; AJ-24136; L-3-Hydroxy-2-aminopropionic acid; UNII-00PAR1C66F component MTCFGRXMJLQNBG-REOHCLBHSA-N; EINECS 200-274-3; TC-066532; L-Serine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%; ZINC895034; TL806218; (L)-SERINE; 61748-67-2; L-Serine, Vetec(TM), 98.5%; L-Serine, PharmaGrade, Ajinomoto, EP, USP, JP, Manufactured under appropriate controls for use in pharma or biopharmaceutical production, suitable for cell culture; NCGC00015952-01; Serine (USP); beta-Hydroxyalanine; L-Serine, BioUltra, >=99.5% (NT); Racemic serine; L-Serin; (S)-beta-Amino-3-hydroxypropionate; L-(-)-Serine; NSC 118365; Pharmakon1600-01301010; BR-73019; AK-73019; AmbotzHAA1129; (-)-Serine; (S)-alpha-Amino-beta-hydroxypropionic acid; (2S)-2-amino-3-hydroxy-propanoic acid; CTK1G9788; GTPL726; 452VLY9402; DB00133; 88848-EP2289892A1; MFCD00064224; l-2-Amino-3-hydroxy-propanoic acid; (S)-(+)-2-Amino-3-hydroxypropionic acid; Tocris-0226; (2S)-2-AMINO-2-CARBOXY-1-HYDROXYETHYL; AKOS015854115; 154605-73-9; bmse000048; alpha-Amino-beta-hydroxypropionic acid; bmse000809; MolPort-003-939-270; ser; LS-144975; 88848-EP2305825A1; (S)-a-Amino-b-hydroxypropionic acid; serine; RP09655; DB-029983; RP18847; AC1L1LHF; L-Serine (JP17); L-Serine, Pharmaceutical Secondary Standard; Certified Reference Material; AC-1190; .beta.-Hydroxyalanine; KSC269O8R; KB-53386; BDBM50357212; RTC-066532; NCGC00024507-02; NSC-760115; Lopac-S-4250; D00016; Serina; Propanoic acid, 2-amino-3-hydroxy-, (S)-; NCGC00024507-01; (S)-2-Amino-3-hydroxypropanoic acid; Polyserine; L-Serine, United States Pharmacopeia (USP) Reference Standard; MCULE-5604658333; AM20100375; (S)-Serine; SC-09827; Tocris-0227; L-2-Amino-3-hydroxypropionic acid; bmse000885; AB1002443; UNII-452VLY9402; beta-Hydroxy-L-alanine; 064S224; Serina [Spanish]; L-Serine, Cell Culture Reagent; HSDB 680; Serine, L-; FT-0693445; Serine, European Pharmacopoeia (EP) Reference Standard; L-serine; 3h-l-serine; C00065; (S)-alpha-Amino-beta-hydroxypropionate; L-Serine, certified reference material, TraceCERT(R); Serine [USAN:INN]; 25821-52-7; .alpha.-Amino-.beta.-hydroxypropionic acid-, (S)-; 2-Amino-3-hydroxypropanoic acid, (S)-; F1905-7047; (S)-2-amino-3-hydroxy-Propanoate; (S)-beta-Amino-3-hydroxypropionic acid; L-Serine, ReagentPlus(R), >=99% (HPLC); (S)-2-Amino-3-hydroxypropionic acid; L-Serine, >=99.0% (NT); SR-01000597708; (S)-2-Amino-3-hydroxypropanoate; AN-24441; ST2408299; BP-13282; (S)-2-amino-3-hydroxy-Propanoic acid; CHEMBL11298; 3-hydroxy-L-Alanine; MTCFGRXMJLQNBG-REOHCLBHSA-N; L-Serine, tested according to Ph.Eur.; D0T6GM; PubChem10994; VC30786; Epitope ID:150900; L-3-Hydroxy-2-aminopropionate; L-3-Hydroxy-alanine; M-6047; FT-0627627; Z1270387256; SR-01000597708-1; 3AB40D3A-043A-488F-8361-D1BF309F842C; 4-04-00-03118 (Beilstein Handbook Reference); AB0008559; (S)-a-Amino-b-hydroxypropionate; SER (IUPAC abbrev); L-Alanine, 3-hydroxy-; L-ser; ACT08366; (S)-b-Amino-3-hydroxypropionate; (S)-b-Amino-3-hydroxypropionic acid; 2-Amino-3-hydroxypropionic acid; Poly-L-serine; ANW-32514; rac-serine;(S)-2-Amino-3-hydroxypropionic acid; 2-Amino-3-hydroxypropanoic acid; Serinum [Latin]; S4311_SIGMA; NCGC00024507-02; NSC 118365; Lopac-S-4250; D00016; (2S)-2-amino-3-hydroxypropanoic acid; (-)-Serine; (2S)-2-amino-3-hydroxy-propionic acid; Propanoic acid, 2-amino-3-hydroxy-, (S)-; (S)-alpha-Amino-beta-hydroxypropionic acid; 6898-95-9; (2S)-2-amino-3-hydroxy-propanoic acid; NCGC00024507-01; L-Serine, homopolymer; CHEBI:17115; (S)-2-Amino-3-hydroxypropanoic acid; Polyserine; Propanoic acid, 2-amino-3-hydroxy-, (S); L-3-Hydroxy-alanine; Tocris-0226; (S)-Serine; Tocris-0227; BRN 1721404; L-2-Amino-3-hydroxypropionic acid; beta-Hydroxy-L-alanine; Serina [Spanish]; Serine (VAN); 84959_FLUKA; alpha-Amino-beta-hydroxypropionic acid; HSDB 680; Serine, L-; C00065; 4-04-00-03118 (Beilstein Handbook Reference); L-3-Hydroxy-2-aminopropionic acid; EINECS 200-274-3; L-Serine (JAN); SER (IUPAC abbrev); Serine [USAN:INN]; 25821-52-7; 78682_FLUKA; 2-Amino-3-hydroxypropanoic acid, (S)-; L-Alanine, 3-hydroxy-; S1315_SIGMA; NCGC00015952-01; Serine (USP); Poly-L-serine; beta-Hydroxyalanine; S4500_SIGMA;L-Serin | C3H7NO3 | 105.09 g/mol | C(C(C(=O)O)N)O |
| TCMBANKIN057959 | gamma-glutamyl-serine | 2-amino-5-[(1,3-dihydroxy-1-oxopropan-2-yl)amino]-5-oxopentanoic acid; AC1NSVYR; γ-glutamyl-serine | C8H14N2O6 | 234.21 g/mol | C(CC(=O)NC(CO)C(=O)O)C(C(=O)O)N |
| TCMBANKIN057965 | arginine | L(+ )-arginine;EINECS 230-571-3; (2S)-2-amino-5-guanidino-pentanoic acid; EINECS 200-811-1; (S)-2-Amino-5-guanidinovaleric acid; DL-Arginine; (L)-Arginine; Arginine hydrochloride(USAN); 1-Amino-4-guanidovaleric acid; L-Ornithine, N5-(aminoiminomethyl)-; W381918_ALDRICH; (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid; Arginine [USAN:INN]; S-(+)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid; L-Arginine, labeled with tritium; AI3-24165; AIDS-121865; (S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid; NSC203450 (HYDROCHLORIDE); A5006_SIAL; (+-)-Arginine; L-Norvaline, 5-((aminoiminomethyl)amino)-; AIDS121865; Lopac0_000077; Tocris-0663; Arginine (VAN); 4455-52-1; CCRIS 3609; BRN 1725413; NCGC00015064-01; (2S)-2-amino-5-(carbamimidamido)pentanoic acid; (2S)-2-amino-5-guanidinopentanoic acid; D02982; Argininum [INN-Latin]; C00062; 7200-25-1; A8094_SIGMA; 11009_FLUKA; Poly(L-arginine); (2S)-2-amino-5-guanidino-valeric acid; Lopac-A-5006; NSC 206269; HSDB 1429; CHEBI:16467; L-Arginine, homopolymer; L-Arginine (9CI); Arginina [INN-Spanish]; 4-04-00-02648 (Beilstein Handbook Reference); (S)-2-amino-5-guanidinopentanoic acid; (S)-2-Amino-5-((aminoiminomethyl)amino)pentanoic acid; Arginine, L- (8CI); L-Arginine (JP15); EU-0100077; L-alpha-Amino-delta-guanidinovaleric acid; NSC7914 (HYDROCHLORIDE); Arginine (USP); 1119-34-2 (HYDROCHLORIDE); Pentanoic acid, 2-amino-5-((aminoiminomethyl)amino)-, (S)-; L-Arg; L-Norvaline, 5-[(aminoiminomethyl)amino]-; 142-49-4; A4474_SIAL; InChI=1/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s; L-Arginin; Arginine, DL-; NCGC00024715-01;AC1ODX8E; [(4S)-5-amino-4-azaniumyl-5-oxopentyl]-(diaminomethylidene)azanium; [AMINO({[(4S)-4-AMMONIO-4-CARBAMOYLBUTYL]AMINO})METHYLIDENE]AZANIUM | C6H14N4O2 | 174.2 g/mol | C(CC(C(=O)O)N)CN=C(N)N |
| TCMBANKIN058149 | isoluteolin | orobol; 5,7,3 ', 4'-tetrahydroxy isoflavone; Santol | C15H10O6 | 286.24 g/mol | C1=CC(=C(C=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O)O |
| TCMBANKIN058221 | apigenin | 520-36-5; Spectrum2_000428; 10798_FLUKA; Biochem Biophys Res Comm 212: 767 (1997); CCRIS 3789; AIDS001401; apigenin-7-olate; KBioGR_002565; KBio3_002887; BSPBio_000368; 5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; HSCI1_000221; Flavone, 4',5,7-trihydroxy-; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-; EINECS 208-292-3; A3145_SIGMA; 7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-1-benzopyran-5-olate; CHEBI:18388; IDI1_000798; NCGC00025057-04; AIDS-001401; NSC 83244; BPBio1_000406; Apigenol; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromenone; NINDS_000798; NCGC00015049-02; 4′,5,7-Trihydroxyflavone; SPBio_002307; Prestwick_719; 2-(4-hydroxyphenyl)-7-oxidanyl-4-oxidanylidene-chromen-5-olate; Spectrum4_001999; Chamomile; KBio1_000798; BRN 0262620; Prestwick2_000414; Prestwick3_000414; SDCCGMLS-0066379.P001; CHEBI:58470; 5,7, 4'-trihydroxyflavone; NCGC00025057-02; 2-(p-Hydroxyphenyl)-5,7-dihydroxychromone; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; APIGENIN; Lopac0_000065; K00045; 4′,5,7-Trihydroxyflavone; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone; NCGC00025057-09; 5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one; ACon1_002450; Oprea1_622293; EU-0100065; nchembio790-comp26; 4',5,7-Trihydroxyflavone; NCGC00025057-08; ND-9076; NCGC00025057-01; MEGxp0_000176; Apigenin; 4',5,7-Trihydroxyflavone; apigenin ; Prestwick1_000414; NCGC00015049-01; ZINC00004495; NCGC00025057-05; Spectrum3_001882; BiomolKI_000078; NCI60_041830; Bio1_001354; ghl.PD_Mitscher_leg0.1194; SPECTRUM200846; A828903; DivK1c_000798; 5-18-04-00574 (Beilstein Handbook Reference); 5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate; C.I. Natural Yellow 1; 461015-54-3; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)- (9CI); 5,7-dihydroxy-2-(4-hydroxyphenyl)chromone; SMP2_000338; BiomolKI2_000082; Prestwick0_000414; Tocris-1227; Lopac-A-3145; Bio1_000865; NSC83244; Versulin; Pelargidenon 1449; Bio1_000376; Spigenin; 5,7,4'-Trihydroxyflavone; ST056301; UCCF 031; SPBio_000416; Apigenine; C01477; CAS-520-36-5; BSPBio_003384 | C15H10O5 | 270.24 | C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O |
| TCMBANKIN058241 | tyrosin;DTY | Benzenepropanoic acid, alpha-amino-4-hydroxy-, (S)-; HSDB 2003; AIDS192306; L-Phenylalanine-4-hydroxy-; EINECS 200-460-4; 4-Hydroxy-L-phenylalanine; Tyrosine (VAN); alpha-Amino-4-hydroxybenzenepropanoic acid, (S)-; AI3-09055; beta-(p-Hydroxyphenyl)alanine; nchembio816-comp11; AIDS192301; AIDS192308; (S)-2-Amino-3-(p-hydroxyphenyl)propionic acid; CHEBI:17895; AIDS-192301; TYR NH3+ COOH; Melanin synthesized from Tyr substrate catalyzed by tyrosinase, sulfonated using sulfur trioxide/DMF complex for 1.5-7 hours; (S)-2-Amino-3-(4-hydroxyphenyl)propionic acid; Tyrosinum [Latin]; (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid; AIDS-192307; 25619-78-7; L-Tyrosine (9CI); 1991-85-1; L-Tyrosine, homopolymer; AIDS018692; (S)-alpha-Amino-4-hydroxybenzenepropanoic acid; L-Tyrosin; 55520-40-6; Tirosina [Spanish]; (-)-alpha-Amino-p-hydroxyhydrocinnamic acid; alpha-Amino-beta-(4-hydroxyphenyl)propionic acid; BB_NC-1194; D00022; C00082; Tyrosine, L- (8CI); Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide, <3 kd fraction; Tyrosine [USAN:INN]; T3754_SIAL; 140-43-2; NCGC00159350-03; T8566_SIGMA; AIDS-192305; AIDS-018692; 2-Amino-3-(4-hydroxyphenyl)propanoic acid, (S)-; AIDS-192308; AIDS-192306; 2-Amino-3-(4-hydroxyphenyl)propanoic acid-(S)-; 93829_FLUKA; alpha-Amino-p-hydroxyhydrocinnamic acid, (-)-; (S)-Tyrosine; T4321_SIAL; L-Tyrosine, monomer; L-Tyrosine (JAN); Propanoic acid, 2-amino-3-(4-hydroxyphenyl)-(S)-; NCGC00159350-02; AIDS192305; W373605_ALDRICH; 46209-14-7; Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide; Tyrosine (USP/INN); FEMA No. 3736; Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs; NSC 82624; Melanin synthesized from Tyr substrate catalyzed by tyrosinase, brominated with N-bromosuccinimide; AIDS192307; (S)-3-(p-Hydroxyphenyl)alanine | C9H11NO3 | 181.19 g/mol | C1=CC(=CC=C1CC(C(=O)O)N)O |
| TCMBANKIN058368 | 2-hydroxyquinoline-4-carboxylic acid | 1.2-dihydro-2-oxoduindine-4-carboxylic acid; 2-hydroxy-4-quinolinecarboxylic acid | C10H7NO3 | 189.17 g/mol | C1=CC=C2C(=C1)C(=CC(=O)N2)C(=O)O |
| TCMBANKIN058437 | Azole | NSC62777; CCRIS 2933; NSC72470; 530573_ALDRICH; Divinylenimine; InChI=1/C4H5N/c1-2-4-5-3-1/h1-5; Divinyleneimine; 83220_FLUKA; Monopyrrole; HSDB 119; 131709_ALDRICH; 1-Aza-2,4-cyclopentadiene; AI3-18817; 109-97-7; CHEBI:19203; Imidole; Pyrrole; EINECS 240-327-8; 1H-Pyrrole, homopolymer; Pyrrol; 45361-50-0; WLN: T5MJ; 30604-81-0; 1H-Pyrrole; PYROLLE; FEMA No. 3386; ZINC01691362; NSC 62777; c0879; W338605_ALDRICH; EINECS 203-724-7; 21995-14-2; pyrrole | C4H5N | 67.09 g/mol | C1=CNC=C1 |
| TCMBANKIN058586 | Prolinum | (-)-Proline (S)-2-Carboxypyrrolidine; 18875-45-1; (2S)-2-pyrrolidinecarboxylic acid; P5607_SIGMA; L-Proline-15N; AIDS018625; 4305-67-3; L-Proline, labeled with carbon-14; L-Proline (JAN); L-(-)-Proline; CHEBI:17203; 37159-97-0; Carboxypyrrolidine; P0380_SIAL; (-)-(S)-Proline; Proline (USP); D00035; NCGC00014017; W331902_ALDRICH; (2S)-pyrrolidine-2-carboxylic acid; (S)-pyrrolidine-2-carboxylic acid; L-Prolin; NSC-97923; P8865_SIAL; nchembio816-comp9; AIDS-018625; L-(2,3-3H)Proline; C00148; 4607-28-7; 81710_FLUKA; (2S)-proline; 608998_ALDRICH; 81709_FLUKA; proline | C5H9NO2 | 115.13 g/mol | C1CC(NC1)C(=O)O |
| TCMBANKIN058891 | alpha-santalal | α-santalal | C15H22O | 218.33 g/mol | CC(=CCCC1(C2CC3C1(C3C2)C)C)C=O |
| TCMBANKIN058892 | alpha-santalol | Santalol, cis,α-;alpha.-Santalol;2-Penten-1-ol, 5-(2,3-dimethyltricyclo(2.2.1.02,6)hept-3-yl)-2-methyl-, stereoisomer; SCHEMBL14363250; 2-Penten-1-ol, 5-(2,3-dimethyltricyclo(2.2.1.0(2,6))hept-3-yl)-2-m; EINECS 204-102-8; 5-(2,3-Dimethyltricyclo(2.2.1.0(2,6))hept-3-yl)-2-methyl-2-penten-1-ol; α-Santalol; LS-102120; Cis-a-Santalol; 2-Penten-1-ol, 5-(2,3-dimethyltricyclo(2.2.1.0(sup 2,6))hept-3-yl)-2-methyl-, (R(Z))-; Argeol; 5-(2,3-Dimethyltricyclo(2.2.1.02,6)hept-3-yl)-2-methyl-2-penten-1-ol stereoisomer; Santalol, alpha-; α-santalol; Arheol; d-alpha-Santalol; cis-alpha-Santalol; ALPHA-SANTALOL; 5-(2,3-Dimethyltricyclo(2.2.1.02,6)hept-3-yl)-2-methylpent-2-en-1-ol, stereoisomer; 2-Penten-1-ol, 5-(2,3-dimethyltricyclo(2.2.1.0(sup 2,6))hept-3-yl)-2-methyl; HSDB 3421; (Z)-alpha-Santalol | C15H24O | 220.35 | CC(=CCCC1(C2CC3C1(C3C2)C)C)CO |
| TCMBANKIN058894 | santalol | α-santalol; (Z)-2-methyl-5-[(1S, 2R, 4R)-2-methyl-3-methylene-2-norbornanyl]pent-2-en-1-ol; (Z)-2-methyl-5-[(1S, 4R, 6R)-6-methyl-5-methylidene-6-bicyclo[2.2.1]heptanyl]pent-2-en-1-ol; (2Z)-2-methyl-5-[(1S, 2R, 4R)-2-methyl-3-methylidenebicyclo[2.2.1]hept-2-yl]pent-2-en-1-ol; (Z)-2-methyl-5-[(1S, 2R, 4R)-2-methyl-3-methylene-norbornan-2-yl]pent-2-en-1-ol; CHEBI:10441; (Z)-beta-santalol; 2-Penten-1-ol, 2-methyl-5-(2-methyl-3-methylene-2-norbornyl)-; beta-Santalenol; 37172-31-9; (1S-(1alpha, 2alpha(Z), 4alpha))-2-Methyl-5-(2-methyl-3-methylenebicyclo(2.2.1)hept-2-yl)-2-penten-1-ol; beta-santalol; CHEBI:10441; cis-beta-santalol; Santalol, beta-; 2-Penten-1-ol, 2-methyl-5-(2-methyl-3-methylenebicyclo(2.2.1)hept-2-yl)-, (1S-(1alpha, 2alpha(Z), 4alpha))-; UNII-1DGG9VW8SA | C15H24O | 220.35 g/mol | CC(=CCCC1(C2CCC(C2)C1=C)C)CO |
| TCMBANKIN059127 | 3-methyl butanone | MIPK; EINECS 209-264-3; NSC 9379; 3-Methyl-2-butanone; WLN: 1Y1&V1; 59600_FLUKA; Methylbutanone (VAN); Methylbutanone; 2-Acetylpropane; 2-Methyl-3-butanone; 3-Methylbutan-2-one [UN2397] [Flammable liquid]; 3-methylbutan-2-one; 3-Methyl butanone; Caswell No. 555A; Methyl isopropyl ketone; Methyl butanone-2; EPA Pesticide Chemical Code 044104; Isopropyl methyl ketone; InChI=1/C5H10O/c1-4(2)5(3)6/h4H,1-3H; 537721_SIAL; 46212_RIEDEL; 563-80-4; 2-Butanone, 3-methyl-; UN2397; ZINC01699949; 3-Methylbutanone; 52325-52-7; NSC9379; 2-Acetyl propane; 2-BUTANONE,3-METHYL METHYL ISOPROPYL KETONE; AI3-24194; Ketone, isopropyl methyl | C5H10O | 86.13 g/mol | CC(C)C(=O)C |
| TCMBANKIN059225 | MIK | ZINC01482107; Shell MIBK; Isobutyl-methylketon;methyl isobutyl ketone; Isopropyl acetone; Caswell No. 574AA; HSDB 148; 2-Pentanone, 4-methyl-;26733-EP2292597A1; 26733-EP2314577A1; i-BuCOMe; CHEBI:82344; 26733-EP2287154A1; TR-001906; methyl-iso-butylketone; 26733-EP2281821A1; 5792-EP2270114A1; 2-Methyl-4-pentanone; methylisobutyl ketone; 1338234-91-5; Shell mibk; 26733-EP2298755A1; MIK; isobutylmethylketone; UN1245; 4-methyl- 2-pentanone; 78042-EP2277868A1; 4-Methyl-2-pentanone, SAJ first grade, >=99.0%; 4-Methyl-2-pentanon; methyl isobutylketone; Methyl Isobutyl Ketone, Pharmaceutical Secondary Standard; Certified Reference Material; AN-42853; Isopropylacetone; 4-methyl-2pentanone; I14-4094; 4-methylpentane-2-one; 4-Methylpentan-2-one; Isobutyl methyl ketone; KS-00000WQF; Methyl-isobutyl-cetone [French]; 26733-EP2371797A1; WLN: 1Y1 & 1V1; CCRIS 2052; 26733-EP2314583A1; EINECS 203-550-1; methylisobutyl-keton; LMFA12000033; D04989; DTXSID5021889; Methylisobutylketon(DUTCH, GERMAN); MolPort-001-789-273; 5792-EP2314558A1; 7726-EP2371797A1; methyl-iso-butylketon; FT-0628744; SCHEMBL13341539; 4-Methyl-2-pentanone, ACS reagent, >=98.5%; 26733-EP2280009A1; UNII-U5T7B88CNP; EPA Pesticide Chemical Code 044105; CTK3J3414; 78042-EP2277870A1; 7726-EP2289897A1; Methyl isobutyl ketone [UN1245] [Flammable liquid]; iso-C4H9COCH3; C19263; 4-Methyl-2-pentanone (MIBK) 100 ng/microl in Methanol; F1908-0087; 78042-EP2298077A1; MIBK; MCULE-2172909634; 2-Methylpropyl methyl ketone; NSC-5712; CJ-23645; TRA0072750; 26733-EP2380873A1; methyl iso-butylketone; 4-Methyl-2-pentanone (MIBK); 4-Methyl-2-pentanone, >=99%; HSDB 148; 2-Pentanone, 4-methyl-; ACMC-1C282; 4-Methyl-2-pentanone, HPLC Grade; NSC 5712; Metyloizobutyloketon; NSC5712; ANW-15892; 26733-EP2272822A1; 26733-EP2301924A1; 26733-EP2305649A1; InChI=1/C6H12O/c1-5(2)4-6(3)7/h5H,4H2,1-3H; 4-Methyl-2-pentanone, suitable for atomic absorption spectrometry, >=99.5%; 5792-EP2280005A1; Metyloizobutyloketon [Polish]; 26733-EP2274983A1; 26733-EP2295430A2; Methylpentan-2-one; 4-Methyl-2-pentanone, ACS, 98.5% min. 500ml; Metilisobutilchetone [Italian]; methyl isobutyl keton; 108-10-1; DSSTox_GSID_21889; 4-01-00-03305 (Beilstein Handbook Reference); 26733-EP2380568A1; 78042-EP2308866A1; 26733-EP2295438A1; Methyl isobutyl ketone [UN1245] [Flammable liquid]; 4-Methyl-2-pentanone, AR, >=99%; M0389; Isohexanone; 26733-EP2371804A1; 26733-EP2308857A1; RCRA waste no. U161; Methyl isobutyl ketone, United States Pharmacopeia (USP) Reference Standard; isobutylmethyl ketone; AI3-01229; CHEMBL285323; Methyl-2-pentanon,4-; 4-Methyl-pentan-2-one; 26733-EP2270009A1; KSC493I1J; 4-Methyl-2-oxopentane; Jsp000704; 78042-EP2301353A1; 4-Methyl-2-pentanone, for HPLC, >=99.5%; 5792-EP2289884A1; Hexon; AC1Q1P3V; 4-Methyl-2-pentanone, >=99%, FCC; NCGC00091475-02; Methyl-isobutyl-cetone; Tox21_201108; 4-Methyl-2-pentanone, analytical standard; 28326-EP2314577A1; CAS-108-10-1; Hexone; NCGC00258660-01; 78042-EP2272846A1; 2-Methyl-4-pentanal; 4-Methyl-2-pentanone, LR, >=99%; FEMA No. 2731; MFCD00008938; Ketone, isobutyl methyl; SCHEMBL15458; Isobutyl-methylketon; 2-Pentanone,4-methyl-; Rcra waste number U161; Caswell No. 574AA; MIe; 4-Methyl-2-pentanone, technical grade, 95%; Methyl isobutyl ketone, p.a., ACS reagent, 98.5%; 78042-EP2305035A1; Methyl isobutyl ketone [USAN]; 26733-EP2371798A1; 78042-EP2298076A1; Methylisobutylketon; J-515799; DSSTox_RID_76387; 5792-EP2289897A1; 5792-EP2292624A1; 78042-EP2305031A1; 26733-EP2269986A1; SC-65434; FEMA Number 2731; CJ-05088; 26733-EP2299326A1; 4-Methyl-2-pentanone, JIS special grade, >=99.5%; 26733-EP2298763A1; DSSTox_CID_1889; 26733-EP2309584A1; 4-Metilpentan-2-one; 78042-EP2305034A1; Q-200495; ZINC1482107; 26733-EP2302003A1; 26733-EP2308838A1; 7726-EP2275423A1; Hexon [Czech]; 4-Methyl-2-pentanon [Czech]; EC 203-550-1; NCGC00091475-01; KB-72711; 128154-EP2295423A1; 4-Methyl-2-pentanone, puriss. p.a., ACS reagent, >=99.0% (GC); 78042-EP2277869A1; 26733-EP2371800A1; A801806; METHYL ISO-BUTYL KETONE; 26733-EP2295431A2; UN 1245; ST51046575; RTR-001906; 2-Methyl-4-oxopentane; Isopropyl acetone; 4-Methyl-pentan-2-on; Methyl isobutyl ketone (NF); Isobutyl-methylketon [Czech]; 4-Methyl-pentan-2-on(DUTCH, GERMAN); methylisobutyl keton; U5T7B88CNP; 4-Metilpentan-2-one [Italian]; 4-Methyl-pentan-2-on [Dutch, German]; MIBe; 26733-EP2295423A1; 26733-EP2289868A1; 4-Methyl-2-pentanone (natural); Methyl isobutyl ketone [NF]; ethyl iso-butyl ketone; 26733-EP2305254A1; iso-butylmethylketone; 78042-EP2275422A1; Metilisobutilchetone; 78042-EP2292608A1; BRN 0605399; BP-13453; 26733-EP2275407A1; 26733-EP2281812A1; methyl-isobutyl ketone; Methylisobutylketon [Dutch, German]; 128154-EP2269986A1; NTIZESTWPVYFNL-UHFFFAOYSA-N; 2-PENTANONE,4-METHYL METHYL,ISOBUTYL,KETONE; 78042-EP2374791A1; methy isobutyl ketone; 26733-EP2377845A1; 26733-EP2272827A1; 4-Methyl-2-pentanone, puriss., ACS reagent, reag. Ph. Eur., 99.0%; 78042-EP2305033A1; methyl-isobutylketone; methylisobutlyketone; Methyl Isobutyl Ketone Reagent Grade ACS; LS-453; AC1L1PTX; methylisobutyketone; Methyl I-butyl ketone; 4-Methyl-2-pentanone; SBB060384; 26733-EP2305650A1; 7726-EP2272848A1; METHYL ISOBUTYL KETONE; AKOS000118793; methylisobutylketone; 4-Methyl-pentan-2-on; 442417_SUPELCO; Methyl isobutyl ketone (NF); NSC 5712; RCRA waste number U161; Isobutyl-methylketon [Czech]; 2-Methyl-4-pentanone; Metyloizobutyloketon; NSC5712; InChI=1/C6H12O/c1-5(2)4-6(3)7/h5H,4H2,1-3H; Metyloizobutyloketon [Polish]; UN1245; 4-Metilpentan-2-one [Italian]; 4-Methyl-pentan-2-on [Dutch, German]; 58600_FLUKA; Methylisobutylketon; 4-Methyl-2-pentanon; Hexanone; Isopropylacetone; Metilisobutilchetone [Italian]; 108-10-1; 4-01-00-03305 (Beilstein Handbook Reference); 4-Methylpentan-2-one; 4-Methyl-2-pentanone (natural); MIBK; Isobutyl methyl ketone; Methyl-isobutyl-cetone [French]; Methyl isobutyl ketone [UN1245] [Flammable liquid]; Metilisobutilchetone; BRN 0605399; Isohexanone; CCRIS 2052; WLN: 1Y1 & 1V1; EINECS 203-550-1; D04989; RCRA waste no. U161; FEMA Number 2731; AI3-01229; 02474_FLUKA; Methylisobutylketon [Dutch, German]; 2-PENTANONE,4-METHYL METHYL,ISOBUTYL,KETONE; 360511_SIAL; 4-Methyl-2-oxopentane; 4-Metilpentan-2-one; W273104_ALDRICH; Methyl-isobutyl-cetone; EPA Pesticide Chemical Code 044105; 537713_ALDRICH; 33463_RIEDEL; 4-Methyl-2-pentanon [Czech]; Hexon [Czech]; NCGC00091475-01; Hexone; 4-Methyl-2-pentanone; Methyl isobutyl ketone; FEMA No. 2731; 293261_ALDRICH; 2-Methylpropyl methyl ketone; Ketone, isobutyl methyl | C6H12O | 100.16 | CC(C)CC(=O)C |
| TCMBANKIN059240 | Isovaleral | Aldehyde isovalerianique [French]; Isopentanal; beta-Methylbutanal; 2-Methylbutanal-4; C07329; 3-Methyl butyraldehyde; 3-Methylbutanal; Isovaleric aldehyde; 1-Butanal, 3-methyl-; Isopentaldehyde; W269212_ALDRICH; Isoamyl aldehyde; WLN: VH1Y1&1; 4-01-00-03291 (Beilstein Handbook Reference); 59820_FLUKA; Butanal, 3-methyl-; beta-Methylbutyraldehyde; InChI=1/C5H10O/c1-5(2)3-4-6/h4-5H,3H2,1-2H; .beta.-Methylbutanal; 3-Methylbutylaldehyde; 590-86-3; EINECS 209-691-5; 3-Methylbutyraldehyde (natural); NSC 404119; BRN 0773692; Butanal, methyl-; CCRIS 2945; NSC404119; Isoamylaldehyde; ZINC00896832; iso-C4H9CHO; W269204_ALDRICH; FEMA No. 2692; AI3-16106; HSDB 628; Isovalerylaldehyde; 3-Methylbutan-1-al; 3-Methylbutyraldehyde; 146455_ALDRICH; CHEBI:16638; 3-Methyl-1-butanal; 26140-47-6; Isovaleraldehyde; Butyraldehyde, 3-methyl-; Butanal,- methyl-; Butanal, 3- methyl-; isovaleraldehyde; 3-methyl butanal | C5H10O | 86.13 | CC(C)CC=O |
| TCMBANKIN059515 | α-teresantalicacid | 166.22 g/mol | CC1(C2CC3C1(C3C2)C)C(=O)O | ||
| TCMBANKIN059516 | teresantalal | C10H14O | 150.22 | CC1(C2CC3C1(C3C2)C)C=O | |
| TCMBANKIN059517 | nortricycloekasantalicacid | C11H16O2 | 180.24 g/mol | CC1(C2CC3C1(C3C2)C)CC(=O)O | |
| TCMBANKIN059827 | phenol,2,6-bis(1,1-dimethylethyl)-4-methyl | C15H24O | 220.35 g/mol | CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C | |
| TCMBANKIN059907 | (+)-alpha-Curcumene | C15H22 | 202.33 g/mol | CC1=CC=C(C=C1)C(C)CCC=C(C)C | |
| TCMBANKIN059917 | methylbenzol | C6H5CH3 | 92.14 g/mol | CC1=CC=CC=C1 | |
| TCMBANKIN059978 | santamarine | C15H20O3 | 248.32 | CC1=CCC(C2(C1C3C(CC2)C(=C)C(=O)O3)C)O | |
| TCMBANKIN059982 | d-limonene | C10H16 | 136.23 g/mol | CC1=CCC(CC1)C(=C)C | |
| TCMBANKIN060013 | 9(10)z,α-trans-bergamotenol | C15H24O | 220.35 g/mol | CC1=CCC2CC1C2(C)CCC=C(C)CO | |
| TCMBANKIN060198 | prosapogenin cp5 | CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C(C3(C)CO)CCC5(C4CC=C6C5(CCC7(C6CC(CC7)(C)C)C(=O)O)C)C)C)O)O)O)OC8C(C(C(CO8)O)O)O)O | |||
| TCMBANKIN060229 | Glycoside H1;kalopanaxsaponin B;akebin b;akebin f;Akeboside sth;tauroside h 2 | C59H96O26 | 1149.48 | CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OCC3C(C(C(C(O3)OC(=O)C45CCC(CC4C6=CCC7C8(CCC(C(C8CCC7(C6(CC5)C)C)(C)CO)OC9C(C(C(CO9)O)O)OC1C(C(C(C(O1)C)O)O)O)C)(C)C)O)O)O)CO)O)O)O | |
| TCMBANKIN060484 | epirockogenin | C27H44O4 | 432.6 g/mol | CC1CCC2(C(C3C(O2)CC4C3(C(CC5C4CCC6C5(CCC(C6)O)C)O)C)C)OC1 | |
| TCMBANKIN060602 | Dihydro-β-agarofuran | C15H26O | 222.37 | CC1CCCC2(C13CC(CC2)C(O3)(C)C)C | |
| TCMBANKIN060707 | monolinolenin | C21H36O4 | 352.5 g/mol | CCC=CCC=CCC=CCCCCCCCC(=O)OCC(CO)O | |
| TCMBANKIN060958 | oleic acid;cis-oleic acid;oleinic acid | C18H34O2 | 282.46 | CCCCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN060997 | undecanoicacid;Undekansaeure | C11H22O2 | 186.29 g/mol | CCCCCCCCCCC(=O)O | |
| TCMBANKIN061029 | myristic acid | C14H28O2 | 228.37 | CCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061045 | PENTADECYLIC ACID | C15H30O2 | 242.4 g/mol | CCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061245 | Acetic ether | C4H8O2 or CH3COOC2H5 | 88.11 g/mol | CCOC(=O)C | |
| TCMBANKIN061590 | isorhamnetin | 3'-O-Methylquercetin; 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxy-phenyl)chromone; 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxy-phenyl)chromen-4-one; Isorhamnetin; BRN 0044723; Flavone, 3,3',5,7-tetrahydroxy-4'-methoxy-; C10084; Quercetin 3'-methyl ether; 3'-Methoxyquercetin; CCRIS 3791; 3,5,7-Trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-benzopyrone; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(3-hydroxy-4-methoxyphenyl)- (9CI); C.I. 75680; 4'-Methoxy-3,3',5,7-tetrahydroxy-flavone; ST5309356; Quercetin, 4'-methyl ether; Flavone, 3'-methoxy-3,4',5,7-tetrahydroxy-; AIDS-003060; 480-19-3; ACon1_000275; AIDS003060; 4'-O-Methylquercetin; 3-Methylquercetin; Oprea1_145406; ZINC00517261; 4'-Methoxyquercetin; NCGC00163572-01; 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one; BRN 0324993; 4H-1-Benzopyran-4-one, 2-(3-methoxy-4-hydroxyphenyl)-3,5,7-trihydroxy-; 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)- (9CI); EINECS 210-050-7; 3'-Methoxy-3,4',5,7-tetrahydroxyflavone; MEGxp0_001863; NCGC00163572-02; EINECS 207-545-5; Isorhamnetol; 3,5,7-Trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone; 17794_FLUKA; FLAVONE, 4'-METHOXY-3,3',5,7-TETRAHYDROXY-; 4'-Methylquercetin; 5-18-05-00496 (Beilstein Handbook Reference); 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-; 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-chromenone; 3-Methylquercetine; FLAVONE, 3,4',5,7-TETRAHYDROXY-3'-METHOXY-; 3-methylquercetin; quercetin-3'-methyl ether | C16H12O7 | 316.26 g/mol | COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O |
| TCMBANKIN061695 | Majudin | Spectrum2_000534; 5-19-06-00004 (Beilstein Handbook Reference); 4-methoxyfuro[3,2-g]chromen-7-one; Spectrum3_000663; KBio3_001545; CCRIS 4348; KBioGR_002055; 4-methoxy-7-furo[3,2-g]chromenone; DivK1c_000529; NCGC00091582-01; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-; KBio2_001274; TNP00299; NINDS_000529; Bergapten; Spectrum5_000155; EINECS 207-604-5; KBio1_000529; 4-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; KBioSS_001274; ACon0_000984; AIDS031096; 4-methoxy-7H-furo[3,2-g]chromen-7-one; HSDB 3466; 5-Methoxypsoralen; Spectrum_000794; KBio2_003842; BSPBio_002325; MEGxp0_000990; 65320_FLUKA; BRN 0019560; 5-Mop; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, gamma-lactone; NCGC00091582-02; Bergaptene; 5-Methoxy psoralen; NCI60_042121; 5-Methoxy-6,7-furanocoumarin; KBio2_006410; 4-Methoxy-furo[3,2-g]chromen-7-one; IDI1_000529; Bergapten(e); BAS 00674110; ACon1_001979; SPBio_000547; 5-Methoxypsoralen with ultraviolet A therapy; BERGAPTAN; Psoraderm; SDCCGMLS-0066492.P001; NSC95437; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-methoxy-; ST057259; ZINC00057731; InChI=1/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H; C01557; Heraclin; NCGC00091582-03; 4-Methoxyfuro[3,2-g]benzopyrane-7-one; 275727_ALDRICH; Spectrum4_001478; SPECTRUM300546; O-Methylbergaptol; 5-Methoxyfuranocoumarin; NSC 95437; NCGC00017357-01; AIDS-031096; 484-20-8; Oprea1_562364; 5-methoxypsoralen; bergapten;5-19-06-00004 (Beilstein Handbook Reference); AB00052148_06; V0122; DivK1c_000529; NCGC00259906-01; KBio2_001274; EINECS 207-604-5; Geralen; SR-05000002173; KBio1_000529; KBioSS_001274; Majudin; 4-Methoxy-7H-furo[3,2-g]chromen-7-one #; 4-Methoxy-7H-furo[3,2-g]chromen-7-one; HMS501K11; 5-Methoxypsoralen, 99%; SMR000112435; NCGC00017357-03; NCGC00017357-07; CAS-484-20-8; B2840; AK134854; KS-00000GSD; TR-017690; Bergapten(e); NCGC00017357-04; BAS 00674110; CC-24574; C-11626; BERGAPTAN; Psoraderm; D07521; SDCCGMLS-0066492.P001; BRD-K12968785-001-03-4; MLS002207272; 5-Methoxypsoralen (Bergapten); InChI=1/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H; Bergaptene (DCF); 5-methoxy-psoralen; Pentaderm (TN); SPECTRUM300546; HY-N0370; ANW-42611; 5-Methoxypsoralen (obsol.); 5-Methoxy psoralen; KBioGR_002055; Oprea1_562364; Tox21_303255; NCGC00178705-02; Q-100536; Spectrum3_000663; BRD-K12968785-001-02-6; 4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one; NCGC00017357-08; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-; ZINC57731; TNP00299; Bergapten; BDBM50067880; Spectrum5_000155; NSC755877; 4-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; AB00052148_07; DS-2970; Spectrum_000794; KBio2_003842; 5-methoxy-2H-furo[3,2-g]chromen-2-one; BRN 0019560; NCGC00178705-01; 5-Mop; UNII-4FVK84C92X; M-9412; NCGC00091582-02; HMS2268M24; CHEBI:18293; CS-2234; 5 methoxypsoralen; 5-methoxypsoralen ; 5-Methoxy-6,7-furanocoumarin; KBio2_006410; NCGC00017357-05; SR-05000002173-5; CCG-39946; 5-Methoxypsoralen with ultraviolet A therapy; DSSTox_CID_5560; NSC95437; CJ-00484; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-methoxy-; ST057259; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, .gamma.-lactone; NCGC00017357-02; N1304; AC1Q47BC; NCGC00091582-03; SBI-0051583.P002; 4-Methoxy-7H-furo[3,2-g]benzopyran-7-one; NSC 95437; 5-methoxyfurano[3,2-g]chromen-2-one; bergaptene; 484-20-8; CTK3J2399; s4239; Spectrum2_000534; Pentaderm; 4FVK84C92X; KBio3_001545; HMS3652F19; ST2411501; NINDS_000529; STK333038; MCULE-7768334865; NCGC00017357-06; HSDB 3466; 5-Methoxypsoralen; BSPBio_002325; CB-1199; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, gamma-lactone; BGEBZHIAGXMEMV-UHFFFAOYSA-N; I14-13388; MFCD00010272; bmse000758; IDI1_000529; AB0019675; DB12216; 4-Methoxyfuro[3,2-g]benzopyrane-7-one; 4-Methoxyfuro[3,2-g]benzopyran-7-one; O-Methylbergaptol; 484B208; RTR-017690; NCGC00091582-04; SC-46077; AKOS000276715; SR-05000002173-3; CCRIS 4348; DSSTox_GSID_25560; 4-methoxyfuro[3,2-g]chromen-7-one; ZB002242; DTXSID1025560; NSC-755877; NCGC00091582-01; 5-methoxypsoralene; AX8014410; A827532; AJ-09777; ACon0_000984; Tox21_202357; HMS1923G13; FT-0603416; MEGxp0_000990; AC1L1DHU; MolPort-000-880-879; NSC-95437; 4CN-0945; NCI60_042121; BG01521510; 4-Methoxy-furo[3,2-g]chromen-7-one; NCGC00256998-01; AC-20189; CHEMBL24171; SPBio_000547; ACon1_001979; DSSTox_RID_77830; 7H-Furo[3, 4-methoxy-; SR-05000002173-2; Bergapten, analytical standard; SCHEMBL50066; 4-methoxy-7-furo[3,2-g][1]benzopyranone; Heraclin; C01557; Bio-0829; Spectrum4_001478; LS-1292; D0QR5G; Pharmakon1600-00300546; 5-Methoxyfuranocoumarin; MLS002454380; NCGC00017357-01; AN-9448 | C12H8O4 | 216.19 g/mol | COC1=C2C=CC(=O)OC2=CC3=C1C=CO3 |
| TCMBANKIN061752 | Syringaldehyde | BP-12551; W-108274; SYRINGIC ALDEHYDE; TL8000818; F2190-0619; 3,5-Dimethoxy-4-hydroxybenzene carbonal; SBB007558; syringaldehyde; Benzaldehyde,5-dimethoxy-4-hydroxy-; 134S963; Syringaldehyde (3,5-Dimethoxy-4-hydroxybenzaldehyde); MolPort-000-871-246; 4-08-00-02718 (Beilstein Handbook Reference); AC-7993; Syringylaldehyde; RP24321; Benzaldehyde, 4-hydroxy-3,5-dimethoxy-; 3,5-Dimethoxy-4-Hydroxy-Benzaldehyde; M-5269; BBL023037; CJ-01202; BB_NC-1418; 3,5-Dimethoxy-4-hydroxybenzaldehyde; 134-96-3; DTXSID2059643; AK-58336; Gallaldehyde 3,5-dimethyl ethel; Syringaldehyde, 98%; EINECS 205-167-5; NSC 41153; AIDS-340410; MCULE-3798898100; CD0099; AB1002509; 86220_FLUKA; FT-0618631; AI3-28796; D0635; Syringealdehyde; S7602_ALDRICH; Syringaldehyde, analytical standard; 4-Hydroxy-3,5-dimethoxybenzaldehydl; AN-8414; CHEBI:67380; AJ-12845; InChI=1/C9H10O4/c1-12-7-3-6(5-10)4-8(13-2)9(7)11/h3-5,11H,1-2H; Syringaldehyde, Vetec(TM) reagent grade, 98%; KCDXJAYRVLXPFO-UHFFFAOYSA-N; BG00602125; 3,5-DIMETHOXY-4-HYDROXYBENZALDEHYDE, PURE; STR09162; UNII-2ZR01KTT21; Syringaldehyde, >=98%, FG; 3,5-Dimethoxy-4-hydroxybenzaldehyde; 4-Hydroxy-3,5-dimethoxybenzaldehyde; TR-004732; ST093694; NSC-41153; RTR-004732; AT-3143; Syringe aldehyde; 4CN-0961; 4-hydroxy-3,5-dimethoxy-benzaldehyde; CTK0H4628; 4-Hydroksy-3,5-dwumetoksybenzaldehyd [Polish]; 3,5-Dimethoxy-4-hydroxy benzaldehyde; ANW-19730; bmse010204; syringaldehye; KSC174M2R; 4-hydroxy-3,5-dimethoxy benzaldehyde; bmse000595; KB-60663; AP-065/41884112; Cedar aldehyde; MFCD00006943; Springaldehyde; ACMC-209bxg; ZINC152926; BRN 0784514; AIDS340410; SC-50428; AKOS000119539; CHEMBL225303; 4-Hydroxy-3,5-dimethoxybenzaldehyde; SYRINGALDEHYDE; NSC41153; SCHEMBL150376; 4-Hydroksy-3,5-dwumetoksybenzaldehyd; CS-0016810; I01-1214; Benzaldehyde, 3,5-dimethoxy-4-hydroxy-; Gallaldehyde 3,5-dimethyl ether; AC1Q489M; AC1L1RFP; STK801968; LS-25017; Syringic aldehyde; 2ZR01KTT21; ZINC00152926; J10333; W404926_ALDRICH; ST2411453;syringic aldehyde;3,5-dimethoxy-4-hydroxybenzaldehyde;yringaldehyde | C9H10O4 | 182.17 g/mol | COC1=CC(=CC(=C1O)OC)C=O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab